Invesco-Ltd

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
14,357
Total Value
320244803394
Accession Number
0000914208-25-000230
Form Type
13F-HR
Manager Name
Invesco-Ltd
Data Enrichment
96% identified
13,831 identified526 unidentified

Holdings

14,357 positions • $320.2B total value
Manager:
Search and click to pin securities to the top
Page 173 of 188
ArriVent BioPharma, Inc.
Shares:11.4K
Value:$210.9K
% of Portfolio:0.0% ($210.9K/$320.2B)
92204A603
Shares:847
Value:$209.7K
% of Portfolio:0.0% ($209.7K/$320.2B)
Verona Pharma plc
Shares:3.3K
Value:$209.3K
% of Portfolio:0.0% ($209.3K/$320.2B)
BigCommerce Holdings, Inc.
Shares:36.2K
Value:$208.4K
% of Portfolio:0.0% ($208.4K/$320.2B)
ADAMS NATURAL RESOURCES FUND, INC.
Shares:9.1K
Value:$208.1K
% of Portfolio:0.0% ($208.1K/$320.2B)
433921103
Shares:143.5K
Value:$208.1K
% of Portfolio:0.0% ($208.1K/$320.2B)
910710102
Shares:17.9K
Value:$207.5K
% of Portfolio:0.0% ($207.5K/$320.2B)
UTAH MEDICAL PRODUCTS INC
Shares:3.7K
Value:$207.5K
% of Portfolio:0.0% ($207.5K/$320.2B)
Savara Inc
Shares:74.1K
Value:$205.4K
% of Portfolio:0.0% ($205.4K/$320.2B)
Shares:90.7K
Value:$205.0K
% of Portfolio:0.0% ($205.0K/$320.2B)
92840N100
Shares:10.2K
Value:$204.9K
% of Portfolio:0.0% ($204.9K/$320.2B)
CERUS CORP
Shares:146.9K
Value:$204.2K
% of Portfolio:0.0% ($204.2K/$320.2B)
Lyell Immunopharma, Inc.
Shares:378.9K
Value:$203.8K
% of Portfolio:0.0% ($203.8K/$320.2B)
Klaviyo, Inc.
Shares:6.7K
Value:$203.6K
% of Portfolio:0.0% ($203.6K/$320.2B)
G85727108
Shares:49.0K
Value:$201.9K
% of Portfolio:0.0% ($201.9K/$320.2B)
08659B102
Shares:16.5K
Value:$201.5K
% of Portfolio:0.0% ($201.5K/$320.2B)
Theravance Biopharma, Inc.
Shares:22.5K
Value:$201.2K
% of Portfolio:0.0% ($201.2K/$320.2B)
OmniAb, Inc.
Shares:83.6K
Value:$200.6K
% of Portfolio:0.0% ($200.6K/$320.2B)
MILLICOM INTERNATIONAL CELLULAR SA
Shares:6.6K
Value:$199.1K
% of Portfolio:0.0% ($199.1K/$320.2B)
Getty Images Holdings, Inc.
Shares:115.0K
Value:$198.9K
% of Portfolio:0.0% ($198.9K/$320.2B)